VK-0214 is an agonist of the thyroid beta receptor (TRbeta). By activating the expression of ABCD2, it can reduce the accumulation of very long-chain fatty acids (VLCFAs) and further alleviate glioblastoma multiforme. VK-0214 has the effect of regulating fatty acid metabolism and can be used in the research of X-linked adrenoleukodystrophy (X-ALD)[1].
Molekulargewicht:
412.42
Reinheit:
99.87
CAS Nummer:
[852949-30-5]
Formel:
C23H25O5P
Target-Kategorie:
Thyroid Hormone Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten